Theorem Clinical Research Inc is categorized under Research and Development Laboratories in Dublin, CA .
Theorem Clinical Research Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Suzanne Dorsey at the company’s branch by writing to 7310 Parkwood Circle, Dublin, California CA 94568 or by phoning (706) 563-2274. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Theorem Clinical Research Inc |
| Contact Person: | Suzanne Dorsey |
| Address: | 7310 Parkwood Circle, Dublin, California 94568 |
| Phone Number: | (706) 563-2274 |
| Website Address: | theoremclinical.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Theorem Clinical Research Inc was started in 0 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Suzanne Dorsey for inquiries that concern Theorem Clinical Research Inc by calling the company number (706) 563-2274, as your correspondence is most welcome. Additionally, the physical location of the branch of Theorem Clinical Research Inc can be found at the coordinates as well as the street address 7310 Parkwood Circle in Dublin, California 94568.
For its online presence, you may visit Theorem Clinical Research Inc’s website at theoremclinical.com and engage with its social media outlets through on Twitter and on Facebook.